Differential diagnosis of myopathy and multiple epiphysal dysplasia caused by mutations in the COMP gene in children

Background. Multiple epiphysal dysplasia (MED) type 1 (OMIM: 132400) is one of 7 genetic variants of this group of skeletal dysplasias described to date. The disease is caused by mutations in the COMP gene located on chromosome 19p13.1. The presence of muscle hypotonia and ligamentous laxity, as well as a moderate increase in the level of creatinephosphokinase activity, can lead to misdiagnosis of myopathy.

Objective: to analyze the clinical and genetic characteristics of type 1 MED caused by mutations in the COMP gene in a series of Russian patients. Differential diagnosis was focused on the distinctive features of the disorder and hereditary myopathies.

Materials and methods. We observed 8 patients from 7 families aged 7 to 15 years with MED type 1 caused by heterozygous mutations in the COMP gene. To confirm the diagnosis, the following methods were used: genealogical analysis, clinical examination, neurological examination with psycho-emotional testing, radiography and targeted sequencing of a panel consisting of 166 genes responsible for the development of inherited skeletal pathology.

Results. Case history, clinical, radiological and genetic characteristics of 8 patients with MED type 1 caused by mutations in the COMP gene were analyzed. The first clinical manifestations of the disease were recorded from the age of 2–3 years and were characterized by gait disturbances, muscle weakness, difficulties with climbing stairs, frequent falls when walking, the inability to get up from the floor and from a squatting position and hypermobility of the joints. Electroneuromyographic study did not reveal the signs of miopathy. In two patients, a moderate increase in the creatinekinase level of up to 250–360 u / l was found. All patients were surveyed by neurologists for several years with a clinical diagnosis of congenital myopathy. At the age of 5–6 years patients COMPlained knee and ankle pain, which was assumed as rheumatic arthropathy. X-ray examination revealed typical signs of deficient ossification of the epiphyses. The next-generation sequencing analysis revealed seven single nucleotide variants in the COMP gene that lead to MED type 1. Three of the found variants here identified for the first time. As previously described, the majority of nucleotide variants (six out of seven) were localized in the 8–14 exons of the COMP gene and led to amino acid substitutions in calmodulin-like protein domain repeats, and only one substitution was localized in the C-terminal region of the protein molecule.

Conclusion. In most patients with MED caused by mutations in the COMP gene, the first symptoms of the disease are gait disturbance, muscle weakness, and Gowers» maneuvers. The presence of these symptoms, along with a moderate increase in the level of creatinephosphokinase activity, often precedes the onset of clinical manifestations of skeletal dysplasia, leading to a misdiagnosis with myopathies. Accession of expressive arthralgias to these symptoms was mistakenly identified as reactive arthritis. X-ray examination of patients’ long bones helps to suspect the presence of MED. This X-ray imaging shows specific signs of epiphyses damage. A molecular-genetic analysis needs to be done to diagnose the genetic variant, caused by mutations in gene COMP.

1. Anthony S., Munk R., Skakun W. et al. Multiple epiphyseal dysplasia. J Am Acad Orthop Surg 2015;23(3):164–72. DOI: 10.5435/JAAOS-D-13-00173.

2. Fairbank H.A. Dysplasia epiphysealis multiplex. Proc R Soc Med 1946;39(6):315–7.

3. Unger S., Bonafé L., Superti-Furga A. Multiple epiphyseal dysplasia: clinical and radiographic features, differential diagnosis and molecular basis. Best Pract Res Clin Rheumatol 2008;22(1):19–32. DOI: 10.1016/j.berh.2007.11.009.

4. Briggs M.D., Hoffman S.M., King L.M. et al. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat Genet 1995;10(3):330–6. DOI: 10.1038/ng0795-330.

5. Hecht J.T., Hayes E., Haynes R. et al. COMP mutations, chondrocyte function and cartilage matrix. Matrix Biol 2005;23(8):525–33. DOI: 10.1016/j.matbio.2004.09.006.

6. Piróg K.A., Jaka O., Katakura Y. et al. A mouse model offers novel insights into the myopathy and tendinopathy often associated with pseudoachondroplasia and multiple epiphyseal dysplasia. Hum Mol Genet 2010;19(1):52–64. DOI: 10.1093/hmg/ddp466.

7. Chapman K.L., Briggs M.D., Mortier G.R. Review: clinical variability and genetic heterogeneity in multiple epiphyseal dysplasia. Pediatr Pathol Mol Med 2003;22(1):53–75. DOI: 10.1080/pdp.22.1.53.75.

8. Piróg K.A., Briggs M.D. Skeletal dysplasias associated with mild myopathy – a clinical and molecular review. J Biomed Biotechnol 2010;2010:686457. DOI: 10.1155/2010/686457.

9. Richards S., Aziz N., Bale S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17(5):405–24. DOI: 10.1038/gim.2015.30.

10. Czarny-Ratajczak M., Lohiniva J., Rogala P. et al. A mutation in COL9A1 causes multiple epiphyseal dysplasia: further evidence for locus heterogeneity. Am J Hum Genet 2001;69(5):969–80. DOI: 10.1086/324023.

11. Chen T.L., Posey K.L., Hecht J.T. et al. COMP mutations: domain-dependent relationship between abnormal chondrocyte trafficking and clinical PSACH and MED phenotypes. J Cell Biochem 2008;103(3):778–87. DOI: 10.1002/jcb.21445.

12. Mabuchi A., Manabe N., Haga N. et al. Novel types of COMP mutations and genotype-phenotype association in pseudoachondroplasia and multiple epiphyseal dysplasia. Hum Genet 2003;112(1):84–90. DOI: 10.1007/s00439-002-0845-9.

13. Liu H.Y., Xiao J.F., Huang J. et al. Diagnosis with multiple epiphyseal dysplasia using whole-exome sequencing in a Chinese family. Chin Med J (Engl) 2017;130(1):104–7. DOI: 10.4103/0366-6999.196568.

14. Jackson G.C., Mittaz-Crettol L., Taylor J.A. et al. Pseudoachondroplasia and multiple epiphyseal dysplasia: a 7-year comprehensive analysis of the known disease genes identify novel and recurrent mutations and provides an accurate assessment of their relative contribution. Hum Mutat 2012;33(1):144–57. DOI: 10.1002/humu.21611.

15. Briggs M.D., Mortier G.R., Cole W.G. et al. Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasiamultiple epiphyseal dysplasia disease spectrum. Am J Hum Genet 1998; 62(2):311–9. DOI: 10.1086/301713.

16. Hartley C.L., Edwards S., Mullan L. et al. Armet/Manf and Creld2 are components of a specialized ER stress response provoked by inappropriate formation of disulphide bonds: implications for genetic skeletal diseases. Hum Mol Genet 2013;22(25):5262–75. DOI: 10.1093/hmg/ddt383.

17. Briggs M.D., Brock J., Ramsden S.C., Bell P.A. Genotype to phenotype correlations in cartilage oligomeric matrix protein associated chondrodysplasias. Eur J Hum Genet 2014;22(11):1278–82. DOI: 10.1038/ejhg.2014.30.

18. Kennedy J., Jackson G.C., Barker F.S. et al. Novel and recurrent mutations in the C-terminal domain of COMP cluster in two distinct regions and result in a spectrum of phenotypes within the pseudoachondroplasia – multiple epiphyseal dysplasia disease group. Hum Mutat 2005;25(6):593–4. DOI: 10.1002/humu.9342.

19. Halász K., Kassner A., Mörgelin M. et al. COMP acts as a catalyst in collagen fibrillogenesis. J Biol Chem 2007;282(43):31166–73. DOI: 10.1074/jbc.M705735200.

20. Tan K., Duquette M., Joachimiak A. et al. The crystal structure of the signature domain of cartilage oligomeric matrix protein: implications for collagen, glycosaminoglycan and integrin binding. FASEB J 2009;23(8):2490–501. DOI: 10.1096/fj.08-128090.

21. Posey K.L., Coustry F., Hecht J.T. Cartilage oligomeric matrix protein: COMPopathies and beyond. Matrix Biol 2018;71–72:161–73. DOI: 10.1016/j.matbio.2018.02.023.

22. Jakkula E., Lohiniva J., Capone A. et al. A recurrent R718W mutation in COMP results in multiple epiphyseal dysplasia with mild myopathy: clinical and pathogenetic overlap with collagen IX mutations. J Med Genet 2003;40(12):942–8. DOI: 10.1136/jmg.40.12.942.